News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Potential Uses Include: Biomarker of Immunity to SARS-CoV-2; Personalized Approach to Timing COVID-19 Vaccine Boosters; Public Health Surveillance; and Serving as an Endpoint for COVID-19 Vaccine Trials

Montana State University
|
February 26, 2022

Their ideas included a virtual reality textbook, a new building material, a food incubator, a device to assist construction workers, various software solutions and a student-focused professional networking platform.

University of Montana
|
February 26, 2022

As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.

Montana BioScience Alliance
|
February 25, 2022

The Montana BioScience Alliance is pleased to announce that Michelle Hood has been inducted into the 2021 MBA Hall of Fame. Ms. Hood is Executive Vice President and Chief Operating Officer of the American Hospital Association and was instrumental in the formation of the Montana BioScience Alliance.

Montana State University
|
February 25, 2022

Soon, someone feeling the need for some extra Z’s may benefit from a wearable device that aids the brain in the biochemical cleansing that leaves a person feeling refreshed after a full night of sleep. As part of the first large-scale study on the effectiveness of the new technology, Montana State University researchers will analyze brain scans of participants who wear a prototype of the device, which works by applying precise electrical stimulation to the brain. The project, which involves multiple universities, […]

ARTICLES OF INTEREST

Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology  that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.

Doctors have told health services to prepare for a new era of cancer screening after a study found a simple blood test could spot multiple cancer types in patients before they develop clear symptoms.

It’s been 60 years since President Kennedy delivered his iconic moonshot speech, marking a goal for America to launch a man into space to step foot on the moon, and bring him back to Earth. On Sept. 12, President Biden gave a speech at the Kennedy Presidential Library in Boston, outlining the progress on his own self-described moonshot: ending cancer.

The National Institute on Aging (NIA) offers early-stage funding opportunities to small businesses and researchers looking to commercialize innovative treatments or technologies to help people enjoy healthier lives as they age. The NIA Small Business Program is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is September 6, 2022. 

The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs offer a lifeline to small medical technology companies that otherwise would not be able to secure the initial funding necessary for expensive research and development.

NEWSLETTER

Newsletter
|
November 30, 2022

View the Fall 2022 now!

Newsletter
|
August 25, 2022